
Enveda Raises $311 Million to Advance AI-Powered Drug Discovery
Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century Enveda, a clinical-stage biotechnology company that uses AI to discover medicines from life’s chemistry, announced the close of a $311 million Series E…














